|
Vílchez JA, Pérez-Cuellar M, Marín F, Gallego P, Manzano-Fernández S, Valdés M, Vicente V, Noguera-Velasco JA, Lip GY, Ordóñez-Llanos J, Roldán V. sST2 levels are associated with all-cause mortality in anticoagulated patients with atrial fibrillation. Eur J Clin Invest. 2015 Sep;45(9):899-905. doi: 10.1111/eci.12482. PubMed PMID: 26081996.
AÑO: 2015; IF: 2.687
|
26081996
|
Cerezo-Manchado JJ, Roldán V, Corral J, Rosafalco M, Antón AI, Padilla J, Vicente V, González-Conejero R. Genotype-guided therapy improves initial acenocoumarol dosing. Results from a prospective randomised study. Thromb Haemost. 2016 Jan;115(1):117-25. doi: 10.1160/TH14-09-0814. Epub 2015 Nov 5. PubMed PMID: 26538428.
AÑO: 2016; IF: 5.627
|
|
de la Morena-Barrio ME, García A, Martínez-Martínez I, Miñano A, Padilla J, Navarro-Fernández J, Roldán V, Águila S, Iniesta JA, Corral J, Vicente V. A new method to quantify ?-antithrombin glycoform in plasma reveals increased levels during the acute stroke event. Thromb Res. 2015 Sep;136(3):634-41. doi: 10.1016/j.thromres.2015.06.039. PubMed PMID: 26186963.
AÑO: 2015; IF: 3.944
|
|
Roldán V, Cancio S, Gálvez J, Valdés M, Vicente V, Marín F, Lip GY. The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study. Am J Med. 2015 Nov;128(11):1237-43. doi: 10.1016/j.amjmed.2015.05.036. PubMed PMID: 26087049.
AÑO: 2015; IF: 5.61
|
|
Esteve-Pastor MA, Roldán V, Valdés M, Lip GY, Marín F. The SAMe-TT2R2 score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation. Expert Rev Cardiovasc Ther. 2016;14(2):177-87. doi: 10.1586/14779072.2016.1116941. Epub 2015 Dec 9. Review. PubMed PMID: 26559964.
AÑO: 2016
|